Got News to Share? Send 2 FREE Releases ↓
All News Topics | Events By Topic | By Country | By State | By Date

18th Annual Symposium on Anti-Angiogenesis and Immune Therapies for Cancer

Submit News
Date: 04-Feb-16 to 06-Feb-16
Location: Hyatt Regency La Jolla / San Diego / United States
Category: Healthcare & Pharmaceuticals Conferences & Trade Fairs

Through didactic presentations, interactive panel discussions, and Q&A sessions, the 2.5 day conference will serve as a platform to discuss and evaluate many of the clinical challenges for optimal integration of anti-angiogenesis and immune-modulating agents into existing treatment paradigms for cancer care, appropriate selection of patients based on biomarker profiles for individualized treatment strategies, and use of these agents in the adjuvant and advanced disease settings.

Featuring presentations from more than 25 investigators, sessions will include:
• Basic Science: Update on Angiogenesis
• Basic Science: Update on Tumor Immunology
• Crosstalk in Tumor Immunology and Preclinical Modeling
• Novel Approaches to Activate the Immune Response to Tumor Antigens
• Controversies with New Therapeutics Targeting Angiogenesis and Tumor Immunology
• Biomarkers and Predictors of Response
• Overview of Clinical Trials of AgentsTargeting Angiogenesis and Tumor Immunology: Clinical Trial Overview

Focusing on both clinical and basic research, topics will focus on cutting edge science in the field, highlighting novel strategies under both pre-clinical and clinical development. We encourage clinicians, scientists, and other healthcare professionals who work in the area of tumor immunology to attend.

Deep discounts are available right now, but expire soon. Rates start as low as $100 for the full conference.

More information antiangioimmuneconference.com.

Exhibitors

Dr. Lee M. Ellis, Dr. Rober Kerbel, Dr. Helen Chen, Dr. George W. Sledge, Dr. Mario Sznol, Dr. Axel Grothey,

Go to event website